Keros Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 27k | 39.76 |
| 2023-09-30 | $791k | 25k | 31.88 |
| 2023-06-30 | $1.1M | 27k | 40.18 |
| 2023-03-31 | $823k | 19k | 42.70 |
| 2022-12-31 | $835k | 17k | 48.02 |
| 2022-09-30 | $374k | 9.9k | 37.62 |
| 2022-06-30 | $396k | 14k | 27.84 |
| 2022-03-31 | $472k | 8.7k | 54.18 |
| 2021-12-31 | $461k | 7.8k | 58.89 |
| 2021-09-30 | $332k | 8.4k | 39.62 |
| 2021-06-30 | $363k | 8.4k | 43.40 |
| 2021-03-31 | $523k | 6.3k | 83.33 |
| 2020-12-31 | $1.9M | 15k | 125.00 |